Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated to v3.6.5, signaling a minor update to the page. This change represents a backend or UI update rather than a modification to study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a small backend/UI update that does not affect the study details or displayed information.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page's documentation or rendering.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag on the page was updated from v3.6.0 to v3.6.2, indicating a platform revision. The change is purely technical and does not affect the study details displayed on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was standardized. The page's revision metadata was updated to Revision: v3.6.0, and additional fields such as 'Last verified' and 'Last known status was' appeared.SummaryDifference1%

- Check67 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page’s documentation/versioning. It does not modify the study details or other critical content.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.